Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases

被引:22
作者
Pan, WT
Liu, H
Xu, YJ
Chen, X
Kim, KH
Milligan, DL
Columbus, J
Hadari, YR
Kussie, P
Wong, WC
Labelle, M
机构
[1] ImClone Syst Inc, Dept Chem, Brooklyn, NY 11226 USA
[2] ImClone Syst Inc, Dept Prot Sci, New York, NY 10014 USA
关键词
kinase inhibitor; oxazepine; FLT-3; aurora;
D O I
10.1016/j.bmcl.2005.08.098
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrimido-oxazepine based sub-micromolar inhibitors (2-4) for Aurora and FLT-3 were designed and synthesized. These preliminary results supported the potential use of pyrimido-oxazepines as a versatile template for developing specific kinase inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5474 / 5477
页数:4
相关论文
共 22 条
[1]  
Banik B. K., 2004, ORGANIC SYNTHESIS, V81, P188
[2]   ZD1839 ('Iressa')1,2 as an anticancer agent [J].
Baselga, J ;
Averbuch, SD .
DRUGS, 2000, 60 (Suppl 1) :33-40
[3]  
BERG S, 2005, Patent No. 2003055492
[4]  
Berg S., 2003, PCT Appl, Patent No. [2003055492, 2003/055492]
[5]   Chemical inhibitors of protein kinases [J].
Bridges, AJ .
CHEMICAL REVIEWS, 2001, 101 (08) :2541-2571
[6]   FLT3 Inhibitors: a paradigm for the development of targeted therapeutics for paediatric cancer [J].
Brown, P ;
Small, D .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (05) :707-721
[7]   The cellular geography of aurora kinases [J].
Carmena, M ;
Earnshaw, WC .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (11) :842-854
[8]   The ErbB receptor family: a therapeutic target for cancer [J].
de Bono, JS ;
Rowinsky, EK .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) :S19-S26
[9]  
Fabbro D, 2002, CURR OPIN DRUG DISC, V5, P701
[10]  
HADARI Y, 2005, Patent No. 2005009384